DK0478665T3 - Antigene epitoper, som er til stede på membranbundet, men ikke udskilt IgA - Google Patents
Antigene epitoper, som er til stede på membranbundet, men ikke udskilt IgAInfo
- Publication number
- DK0478665T3 DK0478665T3 DK90909984T DK90909984T DK0478665T3 DK 0478665 T3 DK0478665 T3 DK 0478665T3 DK 90909984 T DK90909984 T DK 90909984T DK 90909984 T DK90909984 T DK 90909984T DK 0478665 T3 DK0478665 T3 DK 0478665T3
- Authority
- DK
- Denmark
- Prior art keywords
- secreted iga
- antigenic epitopes
- membrane bound
- epitopes present
- bound
- Prior art date
Links
- 230000000890 antigenic effect Effects 0.000 title abstract 2
- 239000012528 membrane Substances 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/867—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody produced via recombinant dna technology
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/369,479 US5079344A (en) | 1989-06-21 | 1989-06-21 | Antigenic epitopes present on membrane-bound but not secreted IgA |
US07/455,080 US5089603A (en) | 1989-06-21 | 1989-12-22 | Antigenic epitopes present on membrane-bound but not secreted iga |
PCT/US1990/003532 WO1990015614A1 (en) | 1989-06-21 | 1990-06-21 | ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0478665T3 true DK0478665T3 (da) | 2000-07-24 |
Family
ID=27004597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90909984T DK0478665T3 (da) | 1989-06-21 | 1990-06-21 | Antigene epitoper, som er til stede på membranbundet, men ikke udskilt IgA |
Country Status (11)
Country | Link |
---|---|
US (2) | US5089603A (de) |
EP (1) | EP0478665B1 (de) |
JP (1) | JP2612512B2 (de) |
AT (1) | ATE189856T1 (de) |
AU (1) | AU645256B2 (de) |
CA (1) | CA2060666C (de) |
DE (1) | DE69033461T2 (de) |
DK (1) | DK0478665T3 (de) |
ES (1) | ES2142790T3 (de) |
SG (1) | SG52589A1 (de) |
WO (1) | WO1990015614A1 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362643A (en) * | 1989-06-21 | 1994-11-08 | Tanox Biosystems | Antibodies to epitopes present on membrane-bound but not secreted IGA |
US5514776A (en) * | 1987-12-31 | 1996-05-07 | Tanox Biosystems, Inc. | Peptides representing antigenic epitopes of dog IgE present on B cell but not basophil surface |
US5266477A (en) * | 1990-02-02 | 1993-11-30 | Pitman-Moore, Inc. | Monoclonal antibodies which differentiate between native and modified porcine somatotropins |
US20100267023A1 (en) * | 1992-09-24 | 2010-10-21 | Keygene N.V. | Selective restriction fragment amplification: fingerprinting |
US7588766B1 (en) | 2000-05-26 | 2009-09-15 | Elan Pharma International Limited | Treatment of amyloidogenic disease |
US7790856B2 (en) * | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
US20080050367A1 (en) * | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US6787523B1 (en) * | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US6761888B1 (en) | 2000-05-26 | 2004-07-13 | Neuralab Limited | Passive immunization treatment of Alzheimer's disease |
US20050059802A1 (en) * | 1998-04-07 | 2005-03-17 | Neuralab Ltd | Prevention and treatment of amyloidogenic disease |
IT1315254B1 (it) * | 1999-11-05 | 2003-02-03 | Diesse Diagnostica Senese Spa | Metodo per la determinazione qualitativa e quantitativa di anticorpiumani di classe igc. |
PE20020574A1 (es) * | 2000-12-06 | 2002-07-02 | Wyeth Corp | Anticuerpos humanizados que reconocen el peptido amiloideo beta |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
US7175988B2 (en) * | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
MY139983A (en) * | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
WO2004069182A2 (en) * | 2003-02-01 | 2004-08-19 | Neuralab Limited | Active immunization to generate antibodies to soluble a-beta |
PE20050627A1 (es) * | 2003-05-30 | 2005-08-10 | Wyeth Corp | Anticuerpos humanizados que reconocen el peptido beta amiloideo |
PL2336147T3 (pl) * | 2003-12-17 | 2015-01-30 | Janssen Alzheimer Immunotherap | Immunogenne koniugaty A beta z nośnikiem peptydowym i sposoby ich otrzymywania |
HUE026000T2 (en) * | 2003-12-17 | 2016-04-28 | Wyeth Llc | Immunogenic peptide-bearing conjugates and methods for their preparation |
PE20061401A1 (es) * | 2004-12-15 | 2006-12-23 | Neuralab Ltd | ANTICUERPOS Aß PARA MEJORAR LA COGNICION |
WO2006066089A1 (en) * | 2004-12-15 | 2006-06-22 | Neuralab Limited | Humanized amyloid beta antibodies for use in improving cognition |
TW200636066A (en) | 2004-12-15 | 2006-10-16 | Elan Pharm Inc | Humanized antibodies that recognize beta amyloid peptide |
EP1941275B1 (de) | 2005-09-29 | 2013-07-24 | Medimmune, Inc. | Verfahren zur identifizierung membran-lg-spezifischer antikörper und verwendung davon zur ansteuerung immunglobulin produzierender vorläuferzellen |
US8784810B2 (en) * | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
RS53402B (en) | 2007-03-22 | 2014-10-31 | Genentech, Inc. | APPLICATION OF APOPTOTIC ANTI-IGE ANTIBODIES FOR MEMBRANE IGE |
US8003097B2 (en) * | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
BRPI0810118A8 (pt) * | 2007-04-18 | 2015-09-29 | Janssen Alzheimer Immunotherap | Método para tratar doença, método para efetuar profilaxia contra caa, uso de um agente, método para reduzir amilóide vascular em um paciente, e, kit para tratamento |
US20080283557A1 (en) * | 2007-05-17 | 2008-11-20 | Julianne Desautels | Spout for food stuff container |
PL2182983T3 (pl) | 2007-07-27 | 2014-10-31 | Janssen Alzheimer Immunotherap | Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta |
JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
MX2011008971A (es) | 2009-02-25 | 2012-02-21 | Alfur F Hung | Anticuerpos anti-cemx que pueden enlazarse a mlge humana en linfocitos b. |
WO2013158274A1 (en) | 2012-04-20 | 2013-10-24 | Academia Sinica | ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS |
CN106029092B (zh) * | 2013-12-05 | 2019-11-19 | 中央研究院 | 能够溶解带有膜锚定型免疫球蛋白a的b淋巴球与降低免疫球蛋白a生产的抗人类膜锚定型免疫球蛋白a抗体 |
CA3079992A1 (en) | 2017-10-31 | 2019-05-09 | Oneness Biotech Co. Ltd. | Treating ige-mediated allergic diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE230883C (de) * | ||||
US4636463A (en) * | 1984-04-05 | 1987-01-13 | Scripps Clinic And Research Foundation | Antibodies to human interleukin-2 induced by synthetic polypeptides |
JP2724625B2 (ja) * | 1987-12-31 | 1998-03-09 | タノックス・バイオシステムズ・インコーポレーテッド | IgE産出性Bリンパ球上の独特な抗原決定基 |
-
1989
- 1989-12-22 US US07/455,080 patent/US5089603A/en not_active Expired - Lifetime
-
1990
- 1990-06-21 DE DE69033461T patent/DE69033461T2/de not_active Expired - Fee Related
- 1990-06-21 DK DK90909984T patent/DK0478665T3/da active
- 1990-06-21 CA CA002060666A patent/CA2060666C/en not_active Expired - Fee Related
- 1990-06-21 ES ES90909984T patent/ES2142790T3/es not_active Expired - Lifetime
- 1990-06-21 SG SG1996006485A patent/SG52589A1/en unknown
- 1990-06-21 AU AU58547/90A patent/AU645256B2/en not_active Ceased
- 1990-06-21 WO PCT/US1990/003532 patent/WO1990015614A1/en active IP Right Grant
- 1990-06-21 EP EP90909984A patent/EP0478665B1/de not_active Expired - Lifetime
- 1990-06-21 JP JP2509317A patent/JP2612512B2/ja not_active Expired - Fee Related
- 1990-06-21 AT AT90909984T patent/ATE189856T1/de not_active IP Right Cessation
-
1991
- 1991-11-04 US US07/785,565 patent/US5866129A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5866129A (en) | 1999-02-02 |
CA2060666A1 (en) | 1990-12-22 |
SG52589A1 (en) | 1998-09-28 |
JPH04504424A (ja) | 1992-08-06 |
ES2142790T3 (es) | 2000-05-01 |
WO1990015614A1 (en) | 1990-12-27 |
DE69033461T2 (de) | 2000-10-12 |
JP2612512B2 (ja) | 1997-05-21 |
EP0478665B1 (de) | 2000-02-23 |
CA2060666C (en) | 2001-07-10 |
AU645256B2 (en) | 1994-01-13 |
EP0478665A1 (de) | 1992-04-08 |
US5089603A (en) | 1992-02-18 |
EP0478665A4 (en) | 1993-02-17 |
AU5854790A (en) | 1991-01-08 |
ATE189856T1 (de) | 2000-03-15 |
DE69033461D1 (de) | 2000-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0478665T3 (da) | Antigene epitoper, som er til stede på membranbundet, men ikke udskilt IgA | |
DK0677533T3 (da) | Antistoffer mod epitoper med homologi til selv-antigener, fremgangsmåder til fremstilling og anvendelser deraf | |
HRP20020721B1 (en) | Novel method for down-regulation of amyloid | |
DK1026239T3 (da) | Ny fremgangsmåde til at udnytte det immunologiske repertoire | |
PT973550E (pt) | Anticorpos antagonistas anti-integrina avb3 | |
NZ219113A (en) | Hiv peptide containing epitope of the env protein | |
ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
FI925043A (fi) | Varianta cd44-ytproteiner, dna-sekvenser som kodar foer dem, antikroppar mot dessa proteiner samt deras anvaendning i diagnos och terapi | |
ATE425251T1 (de) | Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen | |
NO910922L (no) | Tris-maleimidoforbindelser som mellomprodukter i trifunksjonell antistoffsyntese. | |
DE69130396T2 (de) | Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern | |
ATE160575T1 (de) | Für toxin b von clostridium difficile spezifische monoklonale antikörper | |
BR9809656A (pt) | Composição imunopotencializante | |
NO986088L (no) | Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisitet for Rhesus D-antigener, DNA som koder for disse, fremgangsmÕter for fremstilling av disse og anvendelse av disse | |
DK0659276T3 (da) | Immunoassay til eftervisning af collagen eller collagenfragmenter | |
DE69840326D1 (de) | Steigerung der immunantwort unter verwendung von zielgerichteten molekülen | |
DE69928925D1 (de) | Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper | |
ATE207935T1 (de) | Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid | |
DE3485219D1 (de) | Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper. | |
ES2061664T3 (es) | Anticuerpos monoclonales que reconocen a alfa-hanp y correspondientes hibridomas, su preparacion y uso. | |
FI980863A (fi) | Menetelmä juoman ylikuohuntatekijän määrittämiseksi | |
IT8021411A0 (it) | Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione. | |
DK329789A (da) | Monoklonalt antistof | |
ATE28937T1 (de) | Immunotest fuer kohlehydrat-antigen-determinant. | |
NO894555L (no) | Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet. |